BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 29981923)

  • 1. In-silico approach for drug induced liver injury prediction: Recent advances.
    Saini N; Bakshi S; Sharma S
    Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs.
    Hong H; Thakkar S; Chen M; Tong W
    Sci Rep; 2017 Dec; 7(1):17311. PubMed ID: 29229971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach.
    Peng Y; Wu Z; Yang H; Cai Y; Liu G; Li W; Tang Y
    Toxicol Lett; 2019 Sep; 312():22-33. PubMed ID: 31063831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
    Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
    Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints.
    Kim E; Nam H
    BMC Bioinformatics; 2017 May; 18(Suppl 7):227. PubMed ID: 28617228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current challenges and controversies in drug-induced liver injury.
    Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
    Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward predictive models for drug-induced liver injury in humans: are we there yet?
    Chen M; Bisgin H; Tong L; Hong H; Fang H; Borlak J; Tong W
    Biomark Med; 2014; 8(2):201-13. PubMed ID: 24521015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.
    Lin C; Khetani SR
    Biomed Res Int; 2016; 2016():1829148. PubMed ID: 27725933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting drug-induced liver injury in human with Naïve Bayes classifier approach.
    Zhang H; Ding L; Zou Y; Hu SQ; Huang HG; Kong WB; Zhang J
    J Comput Aided Mol Des; 2016 Oct; 30(10):889-898. PubMed ID: 27640149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Identification of Proteins Associated with Drug-induced Liver Injury Based on the Prediction of Drug-target Interactions.
    Ivanov S; Semin M; Lagunin A; Filimonov D; Poroikov V
    Mol Inform; 2017 Jul; 36(7):. PubMed ID: 28145637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid in silico models for drug-induced liver injury using chemical descriptors and in vitro cell-imaging information.
    Zhu XW; Sedykh A; Liu SS
    J Appl Toxicol; 2014 Mar; 34(3):281-8. PubMed ID: 23640866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    Liu Z; Shi Q; Ding D; Kelly R; Fang H; Tong W
    PLoS Comput Biol; 2011 Dec; 7(12):e1002310. PubMed ID: 22194678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure.
    Liu A; Walter M; Wright P; Bartosik A; Dolciami D; Elbasir A; Yang H; Bender A
    Biol Direct; 2021 Jan; 16(1):6. PubMed ID: 33461600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
    Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
    J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
    Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
    Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures.
    Shin HK; Kang MG; Park D; Park T; Yoon S
    Front Pharmacol; 2020; 11():67. PubMed ID: 32116729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.